Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fleisher

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cytometry|January 1, 1992
Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparationsP H Carter, S Resto-Ruiz, G C Washington, et al.
The Journal of Pediatrics|November 20, 1998
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosisA J Infante, H A Britton, T DeNapoli, et al.
The Journal of Rheumatology|February 11, 1999
A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measuresE M Adams, F Pucino, C Yarboro, et al.
Rheumatology (Oxford, England)|February 24, 2007
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritisG G Illei, C H Yarboro, T Kuroiwa, et al.
Human Gene Therapy|February 27, 1999
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA geneC Dunbar, L Chang, C Mullen, et al.
Science (New York, N.Y.)|October 20, 1995
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 yearsR M Blaese, K W Culver, A D Miller, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cytometry|January 1, 1992
Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparationsP H Carter, S Resto-Ruiz, G C Washington, et al.
The Journal of Pediatrics|November 20, 1998
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosisA J Infante, H A Britton, T DeNapoli, et al.
The Journal of Rheumatology|February 11, 1999
A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measuresE M Adams, F Pucino, C Yarboro, et al.
Rheumatology (Oxford, England)|February 24, 2007
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritisG G Illei, C H Yarboro, T Kuroiwa, et al.
Human Gene Therapy|February 27, 1999
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA geneC Dunbar, L Chang, C Mullen, et al.
Science (New York, N.Y.)|October 20, 1995
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 yearsR M Blaese, K W Culver, A D Miller, et al.
Pageof 2